Yield10 Bioscience (YTEN) has signed a non-binding Letter of Intent with Marathon Petroleum (MPC) for a potential investment and offtake agreement for low-carbon intensity Camelina feedstock oil for use in renewable fuels production. Marathon is a leading, integrated downstream energy company in the U.S. In connection with the execution of the LOI, the Company also sold and issued a senior unsecured convertible promissory note to an affiliate of Marathon in the original principal amount of $1M, which is convertible into shares of the Company’s common stock or other Qualified Securities, subject to certain conditions and limitations set forth in the Convertible Note. The Company plans to use the net proceeds from the Convertible Note for working capital and general corporate purposes. Additional information regarding the Convertible Note will be included in a Form 8-K to be filed by the Company with the Securities and Exchange Commission.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on YTEN:
- Yield10 Bioscience and Marathon Petroleum Corporation Sign LOI for Potential Investment and Offtake Agreement for Camelina Feedstock Oil for Renewable Fuels
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial Results
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023